Are you treating ypN0 patient with adjuvant abemaciclib? | ESMO Open;8(3): 101217, 2023 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Are you treating ypN0 patient with adjuvant abemaciclib?

Toss, A; Moscetti, L.

Affiliation

Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: angela.toss@unimore.it.
Moscetti L; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena.

ESMO Open ; 8(3): 101217, 2023 Jun.

Article in En | MEDLINE | ID: mdl-37079950

Subject(s)

Aminopyridines; Benzimidazoles; Humans; Aminopyridines/pharmacology; Aminopyridines/therapeutic use; Benzimidazoles/pharmacology; Benzimidazoles/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Aminopyridines Limits: Humans Language: En Journal: ESMO Open Year: 2023 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Aminopyridines Limits: Humans Language: En Journal: ESMO Open Year: 2023 Document type: Article